Cleaning, disinfection and sterilization

Published on 27/02/2015 by admin

Filed under Anesthesiology

Last modified 22/04/2025

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 1859 times

Chapter 21 Cleaning, disinfection and sterilization

Introduction

All staff involved with anaesthetic equipment have a duty of care to ensure that the risk of hospital-acquired infection from anaesthetic equipment is kept to an absolute minimum. To this end in the UK, guidelines on infection control in anaesthesia were first published by the Association of Anaesthetists of Great Britain and Ireland (AAGBI) in 2002 and updated in 2008.1 Also in the UK, healthcare organizations now have a legal responsibility to implement changes to reduce healthcare-associated infections (HCAIs). The Health Act 20062 provided the Healthcare Commission with statutory powers to enforce compliance with the Code of Practice for the Prevention and Control of Healthcare Associated Infection.

Although there are only a limited number of published reports relating to cross-infection,3,4 the AAGBI recommendation was that all reusable anaesthetic equipment must be appropriately decontaminated prior to patient use and single-use items must be discarded immediately following use. Unfortunately, wide variation in decontamination practices between anaesthetic departments is well recognized. This can be avoided by ensuring that every hospital has a comprehensive infection control policy in place for all anaesthetic equipment, with a nominated anaesthetist and infection control doctor (ICD) taking lead responsibilities.5 Such a policy should be evidenced-based and subject to periodic audit and review. Other useful UK web-based resources include the National Resource for Infection Control and the NHS Library (Surgery, Theatres and Anaesthesia Specialist Library). Key areas requiring risk assessment are listed in Table 21.1.

The aim of this chapter is not to be prescriptive, but to provide the necessary background information for a hospital to formulate its own anaesthetic equipment infection control policy in order to minimize the risk of HCAIs and comply with the UK’s ‘Health Act 2006’.2

Risk assessment and the decontamination process

Contaminated medical devices are typically classified into three infection risk categories:6

If disposable anaesthetic equipment is chosen (Fig. 21.1), then a risk assessment may not be required. However, it is important to remember that disposable equipment will be for ‘single use’ or ‘single patient use’ only. ‘Single use’ indicates that the manufacturer intends the item to be used once only on an individual patient and then discarded. The packaging will be labelled either ‘Single use’, ‘Do not re-use’ or with the symbol image.

’Single patient use’ indicates that the manufacturer advises that the item may be used more than once on the same patient.7 Examples of ‘single patient use’ items in anaesthesia include ventilator tubing and bacterial/viral filters used in critical care units.

By its nature, reusable anaesthetic equipment poses an intermediate or high (if used on broken mucous membranes or skin) risk of infection. Consequently, decontamination by sterilization or disinfection is required. However, the responsibility for choosing the correct decontamination method lies with the sterile services department (SSD) manager, supported by the ICD, the lead clinician and the relevant manufacturer’s guidance. This is because the choice of decontamination method will depend on a number of factors, including the nature of the contamination, the time required for processing, the heat, pressure, moisture and chemical tolerance of the item, the availability of the processing equipment and the risks associated with the decontamination method. Furthermore, decontamination performed in SSDs will ensure that procedures are undertaken in a controlled and standardized manner, as well as being subject to audit review. Consequently, detailed knowledge of decontamination processes is not required by users. However, a sound understanding of the principles and level of decontamination required is essential, to ensure that a local infection control policy is both practical and supported by all staff involved in intensive care and anaesthetic practice. This also applies to the purchase or loan of any new anaesthetic equipment, since a preliminary decontamination assessment must be made prior to its use on patients.

Terminology

Cleaning

This is the physical removal of infectious agents or organic matter. It involves washing with a solvent (usually water and detergent), which may be heated (e.g. thermal washer disinfection, Fig. 21.2). This process does not necessarily destroy infectious agents. It is an essential process prior to disinfection or sterilization to remove bioburden. Items may also be placed in a water bath incorporating an ultrasound generator (Fig. 21.3). The ultrasound causes the water to vibrate at high frequencies so that it literally ‘shakes’ off organic matter. Ultrasonic washers are particularly useful for equipment where conventional cleaning methods might not reach some aspects of the device, or where items are too delicate to be physically scrubbed (e.g. some ophthalmic instruments).

Infection control strategies

Factors to be considered

Single-use versus reusable anaesthetic equipment

Infection control measures have been greatly simplified with the introduction of single-use anaesthetic equipment. Decontamination issues, already outlined with reusable equipment, will not be relevant. However, when preparing an option appraisal, the revenue, procurement and waste disposal costs of single-use equipment needs to be balanced against capital procurement costs for new equipment and SSD charges for reprocessing items. In addition, careful thought needs to be given to where disposable equipment will be stored. To avoid compromising environmental cleaning standards, good communication is required between theatre and supply managers. An example of a local infection control policy for anaesthetic equipment is shown in Table 21.2.

Table 21.2 An example of a local infection control policy for anaesthetic equipment

EQUIPMENT ACTION COMMENT
Airways    
 Oral/nasopharyngeal Single-use  
 Plastic endotracheal Single-use  
 Tracheostomy tubes Single-use  
Angle pieces Single-use  
Catheter mounts Single-use  
Red rubber endotracheal Return to SSD  
Reusable laryngeal masks Return to SSD 40 uses maximum*
Single-use laryngeal masks (and other supraglottic airway devices) Single-use  
Anaesthetic breathing systems (theatres) Disposable AAGBI recommends that anaesthetic circuits are changed on a weekly basis. A bacterial/viral filter should be used with every patient. Change between patients if visibly contaminated or used for highly infectious cases, e.g. tuberculosis.4
External surfaces routinely cleaned with detergent wipes between cases.13
Circle absorbers As for ventilators (see below) Single-use bacterial/viral filter for each patient
Anaesthetic masks Single-use  
Bougies    
 Gum elastic Return to SSD Five uses maximum*
 Others Single-use  
Entonox delivery system (including mouthpiece/mask, tubing, one-way expiratory demand valve) Single-use  
Laryngoscope blades and handles Return to SSD or single use  
Manual resuscitators (self-inflating bags used at resuscitation) Single-use  
Oxygen mask and tubing Single-use  
Paediatric resuscitaire, facemask and tubing Single-use  
Temperature probes Single-use  
Ventilators (anaesthetic machine) Routine disinfection not required except for external surfaces. Follow cleaning and maintenance policies for specific ventilators In ICU, bacterial/viral filter placed on ventilator expiratory port and changed daily* or sooner since single-patient use only
Ventilator tubing (ICU) Disposable Change circuits weekly or sooner since single patient use only (see above)
Flexible fibre-optic laryngoscopes and bronchoscopes Reusable following national guidelines8 Only reprocessed in a specialist endoscopy unit

*Manufacturers’ recommendation; SSD, Sterile Services Department; ICU, Intensive Care Unit; AAGBI, Association of Anaesthetists of Great Britain and Ireland. (After King and Cooke 20013 with permission from The Hospital Infection Society.)

Disinfection or sterilization

Decontamination by heat rather than by chemicals is always preferred. Disinfection by washer-disinfectors (Fig. 21.2) or low temperature steam is commonly employed, since autoclaving (with dry saturated steam) may damage anaesthetic equipment that is repeatedly processed.5 Equipment used for invasive procedures or that comes into contact with broken skin or mucous membranes always requires sterilization.

Centralization of decontamination services

When preparing an infection control action plan, it should be agreed at the outset with all relevant parties, that reprocessing of contaminated anaesthetic equipment should, whenever possible, be undertaken outside the clinical environment in central decontamination units or SSDs (Fig. 21.5).1,6 Stand-alone autoclaves in theatres are not acceptable. Their use necessitates instrument cleaning (the most important component of the decontamination process) within the theatre complex. Furthermore, the scrupulous quality control measures required for the safe use of autoclaves cannot be guaranteed outside non-specialist areas.

Heat-labile instruments

Items of equipment needing high-level disinfection, but unable to tolerate high temperatures, such as endoscopes, pose particular infection control problems. Their decontamination should be undertaken in designated endoscopy units with appropriately trained personnel.7 The use of chemical disinfectants, because of their toxicity, needs to be strictly controlled and subject to risk assessments in accordance with the Control of Substances Hazardous to Health Regulations, COSHH.9

Endoscope processing

Tracking of reusable anaesthetic equipment

SSDs must have tracking systems in place (Fig. 21.8) to enable reusable instruments to be traced to an individual patient in the event of a ‘clinical incident’; for example, failure of the decontamination process or instruments being used on a patient with previously unsuspected Creutzfeldt–Jakob disease (CJD).12 Furthermore, some reuseable anaesthetic equipment (e.g. laryngeal masks, gum elastic bougies) can only be reprocessed a finite number of times according to the manufacturers’ instructions. A suitable tracking system therefore needs to be agreed between SSD and theatre staff, so that specific items of equipment are discarded after the maximum permitted number of uses. Single-use equipment overcomes the need for tracking systems to be in place.

Bacterial/viral filters and anaesthetic breathing systems

Bacterial/viral filters can be used to protect anaesthetic breathing systems from contamination. Although their role in the prevention of nosocomial pneumonia is controversial,15 the AAGBI do recommend that a new bacterial/viral filter be used for every patient.1 Similarly, implementation of a local policy on the reuse of breathing systems in line with manufacturers’ instructions is recommended. Some breathing systems are marketed with instructions which permit reuse for a period of up to 1 week, if a new bacterial/viral filter is used with every patient. However, to ensure consistent application of infection control policies the AAGBI now recommends that anaesthetic circuits are routinely changed on a daily basis (see Table 21.2).

Prion disease

Abnormally shaped prion proteins are implicated as the causative agents in transmissible spongiform encephalopathies, of which variant (v) and sporadic CJD are examples. Both result in progressive neurological symptoms and death. Data from the CJD surveillance unit in Edinburgh indicates that deaths in the UK due to definite and possible cases of CJD amounted to 1476 from 1990 to March 2010.16 Of these, only 168 are considered to be due to vCJD whilst sporadic CJD accounts for 1129 cases. Iatrogenic CJD (due to accidental transmission during medical or surgical procedures) has numbered between 0 and 6 cases per year and is mostly secondary to blood products and soft-tissue allografts. There have been no known transmissions of vCJD via surgery or use of tissues or solid organs.17

There remain a number of uncertainties concerning diagnosis, transmission and incubation periods for prion-related disease. However, the key infection control issue is the presence of microscopic traces of tissue which may remain on surgical instruments after standard decontamination procedures, which could transmit prion protein if inoculated into another patient. There has been no evidence of droplet-transmission. In both types of CJD, the highest concentration of prion protein occurs in the brain, spinal cord and posterior eye. With vCJD, the abnormal prion protein has also been detected in the appendix, tonsils, spleen and gastrointestinal lymph nodes.

The prion protein is remarkably resistant to conventional methods of disinfection and sterilization.17 Standard washing techniques do reduce the concentration of prions in an exponential fashion, but 10–20 cycles are required to produce negligible levels. Standard decontamination methods will not protect against transmission of prion proteins, although the risk of transmission by surgical equipment from patients with undiagnosed CJD is thought to be minimal. Specific decontamination processes, which are the specialist realm of SSDs, have been recommended by the Advisory Committee on Dangerous Pathogens and the Transmissible Spongiform Encephalopathy Working Group and the National Institute for Health and Clinical Excellence.12,17

From the anaesthetic perspective, the transmission of prion disease can be reduced by the strict adherence to standard universal infection control precautions and the employment of single-use instruments when they are considered to be as reliable and safe as reuseable alternatives. To avoid contamination by tonsillar and adenoid tissue in adenotonsillectomy, laryngeal masks, bougies and other intubation aids should not be reused. However, the AAGBI does not recommend the mandatory use of disposable laryngoscopes if laryngoscopy could be difficult, in view of the extremely low risk of transmission.1

Equipment used on definite, probable, possible or ‘at risk’ CJD patients should be dealt with as follows:17

References

1 Association of Anaesthetists of Great Britain and Ireland. Infection control in anaesthesia. Anaesthesia. 2008;63:1027–1036.

2 Department of Health. The Health Act 2006: Code of practice for the prevention and control of healthcare associated infections. Revised 2008. London: DoH Publications; 2008.

3 Neal TJ, Hughes CR, Rothburn MM, Shaw NJ. The neonatal laryngoscope as a potential source of cross-infection. J Hosp Infect. 1995;30:315–317.

4 Mehtar S, Drubu YJ, Vijeratnam S, Meyet F. Cross-infection with Streptococcus pneumoniae through a resuscitaire. Br Med J. 1986;295:25–26.

5 King TA, Cooke RPD. Developing an infection control policy for anaesthetic equipment. J Hosp Infect. 2001;47:257–261.

6 Medicines and Healthcare Products Regulatory Agency. Sterilisation, disinfection and cleaning of medical equipment: guidance on decontamination from the Medical Advisory Committee to Department of Health. Parts 1, 2 and 3. London: DoH; 2010.

7 Medical Devices Agency. Single-use medical devices: implications and consequences of reuse. MDA DB 2000(04). London: Medical Devices Agency; 2000.

8 Medical Devices Agency. Decontamination of endoscopes. MDA DB 2002 (05). London: Medical Devices Agency; 2002.

9 Health and Safety Executive. Control of Substances Hazardous to Health Regulations 2002 (as amended, fifth edition): Approved Code of Practice and guidance. London: HSE Books; 2005.

10 Jeske HC, Tiefenthaler W, Hohlrieder M, Hinterberger G, Benzer A. Bacterial contamination of anaesthetists’ hands by personal mobile phone and fixed phone use in the operating theatre. Anaesthesia. 2007;62:904–906.

11 Fukada T, Iwakiri H, Ozaki M. Anaesthetists’ role in computer keyboard contamination in an operating room. Journal of Hospital. Infection. 2008;70:148–153.

12 NHS Estates. A guide to the decontamination of reusable surgical instruments. Leeds: NHS Estates; 2003.

13 Baillie JK, Sultan P, Graveling E, Forrest C, Lafong C. Contamination of anaesthetic machines with pathogenic organisms. Anaesthesia. 2007;62:1257–1261.

14 Bucx MJL, Veldman DJ, Beenhakker MM, Koster R. The effect of steam sterilisation at 134°C on light intensity provided by fibrelight Macintosh laryngoscopes. Anaesthesia. 1999;54:875–878.

15 Lorente L, Lecuona M, Málaga J, Revert C, Mora ML, Sierra A. Bacterial filters in respiratory circuits: an unnecessary cost? Crit Care Med. 2003;31:2126–2130.

16 National Creutzfeldt-Jakob Disease Surveillance Unit, www.cjd.ed.ac.uk/figures.

17 Advisory Committee on Dangerous Pathogens and the Transmissible Spongiform Encephalopathy Working Group. Transmissible spongiform encephalopathy agents: safe working and the prevention of infection: part 4. London: DoH; 2010.